Clostridium difficile-associated diarrhea - the new scourge of the health care facility.
作者信息
Conly J
机构信息
University Health Network, University of Toronto, Toronto, Ontario, Canada.
出版信息
Can J Infect Dis. 2000 Jan;11(1):25-7. doi: 10.1155/2000/608154.
Abstract
摘要
相似文献
1
Clostridium difficile-associated diarrhea - the new scourge of the health care facility.
Can J Infect Dis. 2000 Jan;11(1):25-7. doi: 10.1155/2000/608154.
2
Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables.在一家急症护理医院和一家专业护理机构中，用一次性体温计取代电子体温计时艰难梭菌相关性腹泻发病率的降低。
Infect Control Hosp Epidemiol. 1992 Feb;13(2):98-103. doi: 10.1086/646480.
3
Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.艰难梭菌（梭状芽孢杆菌）相关疾病：沙特阿拉伯一家综合医院患者中的流行病学情况。
Am J Infect Control. 2020 Oct;48(10):1152-1157. doi: 10.1016/j.ajic.2020.01.011. Epub 2020 Feb 29.
4
Prevalence of Clostridium difficile infection in acute care hospitals, long-term care facilities, and outpatient clinics: Is Clostridium difficile infection underdiagnosed in long-term care facility patients?在急性护理医院、长期护理机构和门诊诊所中艰难梭菌感染的流行情况：在长期护理机构患者中艰难梭菌感染是否被漏诊？
Am J Infect Control. 2017 Oct 1;45(10):1157-1159. doi: 10.1016/j.ajic.2017.04.288.
5
National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.2008年美国医疗机构住院患者中艰难梭菌的全国现患率。
Am J Infect Control. 2009 May;37(4):263-70. doi: 10.1016/j.ajic.2009.01.001. Epub 2009 Mar 10.
6
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.腹泻发作和泻药治疗的实时电子追踪可验证艰难梭菌临床检测标准并降低艰难梭菌感染率。
J Clin Microbiol. 2017 May;55(5):1276-1284. doi: 10.1128/JCM.02319-16. Epub 2017 Mar 1.
7
High frequency of toxigenic and coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá, Colombia.在哥伦比亚波哥大的医疗机构发病（HCFO）和社区发病（CO）中心的腹泻患者中，产毒和合并感染的频率较高。
Gut Pathog. 2019 Jun 3;11:27. doi: 10.1186/s13099-019-0308-7. eCollection 2019.
8
The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility.在一家急症护理机构中使用加替沙星和左氧氟沙星后艰难梭菌相关性腹泻及非艰难梭菌相关性腹泻的发生率。
Clin Infect Dis. 2004 Aug 15;39(4):602-3. doi: 10.1086/422525.
9
[Clostridium difficile isolation in children hospitalized with diarrhea].[腹泻住院儿童艰难梭菌的分离]
An Pediatr (Barc). 2015 Jun;82(6):417-25. doi: 10.1016/j.anpedi.2014.07.015. Epub 2014 Sep 10.
10
The Efficacy of a Mix of Probiotics ( LMG P-27481 and GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial.益生菌组合（LMG P - 27481和GG ATCC 53103）预防住院患者抗生素相关性腹泻和感染的疗效：单中心、开放标签、随机试验
Microorganisms. 2024 Jan 18;12(1):198. doi: 10.3390/microorganisms12010198.
引用本文的文献
1
Compositional dynamics of the human intestinal microbiota with aging: implications for health.人类肠道微生物菌群随年龄变化的组成动力学：对健康的影响。
J Nutr Health Aging. 2014 Nov;18(9):773-86. doi: 10.1007/s12603-014-0549-6.
2
The trends in antibiotic use by general dental practitioners in the Czech Republic (2006-2012).捷克共和国普通牙科医生的抗生素使用趋势（2006 - 2012年）
Int Dent J. 2014 Jun;64(3):138-43. doi: 10.1111/idj.12089. Epub 2014 Jan 11.
3
Clostridium difficile: The evolving story.艰难梭菌：不断演变的故事。
Can J Infect Dis Med Microbiol. 2007 Nov;18(6):341-5. doi: 10.1155/2007/615827.
4
Physical Plant Design and Engineering Controls to Reduce Hospital-acquired Infections.减少医院获得性感染的物理设施设计与工程控制措施
Can J Infect Dis Med Microbiol. 2006 May;17(3):151-3. doi: 10.1155/2006/390985.
5
The impact of health care restructuring on nosocomial infections and transmission of antimicrobial resistant organisms.医疗保健结构调整对医院感染及抗菌药物耐药菌传播的影响。
Can J Infect Dis. 2001 Sep;12(5):271-4. doi: 10.1155/2001/931796.
本文引用的文献
1
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.艰难梭菌的原发性无症状定植与后续腹泻风险降低
Lancet. 1998 Feb 28;351(9103):633-6. doi: 10.1016/S0140-6736(97)08062-8.
2
3
Pathogenesis of Clostridium difficile-associated diarrhoea.艰难梭菌相关性腹泻的发病机制
Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1041-7. doi: 10.1097/00042737-199611000-00003.
4
Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.住院患者艰难梭菌的患病率及致病性。一项法国多中心研究。
Arch Intern Med. 1996 Jul 8;156(13):1449-54.
5
Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.艰难梭菌F血清型菌株产生毒素B，但不产生毒素A。
J Med Microbiol. 1993 Jun;38(6):434-41. doi: 10.1099/00222615-38-6-434.
6
Epidemiology of community-acquired Clostridium difficile-associated diarrhea.
J Infect Dis. 1994 Jan;169(1):127-33. doi: 10.1093/infdis/169.1.127.
7
8
Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea.艰难梭菌相关性腹泻的流行病学、临床表现及转归
Am J Gastroenterol. 1994 Apr;89(4):519-23.
9
Clostridium difficile colitis.艰难梭菌结肠炎
N Engl J Med. 1994 Jan 27;330(4):257-62. doi: 10.1056/NEJM199401273300406.
10
CDAD rates.
Infect Control Hosp Epidemiol. 1995 Feb;16(2):63-5. doi: 10.1086/647056.
Zotero 插件